Navigation Links
Myalgia Global Clinical Trials Review, H2, 2014
Date:8/5/2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Myalgia Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256141/Myalgia-Global-Clinical-Trials-Review-H2-2014.html

Myalgia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Myalgia Global Clinical Trials Review, H2, 2014" provides data on the Myalgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myalgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myalgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Myalgia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Myalgia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Myalgia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Myalgia 25

Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Myalgia Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Laboratorio Brasileiro de Biologia 32
Clinical Trial Overview of Laboratorio Brasileiro de Biologia 32
Idea AG 33
Clinical Trial Overview of Idea AG 33
Hisamitsu Pharmaceutical Co., Inc. 34
Clinical Trial Overview of Hisamitsu Pharmaceutical Co., Inc. 34
Forest Laboratories, Inc. 35
Clinical Trial Overview of Forest Laboratories, Inc. 35
Dil Ltd. 36
Clinical Trial Overview of Dil Ltd. 36
Daiichi Sankyo Company, Limited 37
Clinical Trial Overview of Daiichi Sankyo Company, Limited 37
Covigilance sro 38
Clinical Trial Overview of Covigilance sro 38
Cellex K.K. 39
Clinical Trial Overview of Cellex K.K. 39
C. H. Boehringer Sohn AG & Co. KG 40
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 40
Acceleron Pharma, Inc. 41
Clinical Trial Overview of Acceleron Pharma, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Islamic Azad University of Tabriz 42
Clinical Trial Overview of Islamic Azad University of Tabriz 42

Kurdistan University of Medical Sciences 43
Clinical Trial Overview of Kurdistan University of Medical Sciences 43
Karolinska Institute 44
Clinical Trial Overview of Karolinska Institute 44
Creighton University 45
Clinical Trial Overview of Creighton University 45
Hartford Hospital 46
Clinical Trial Overview of Hartford Hospital 46
Haukeland University Hospital 47
Clinical Trial Overview of Haukeland University Hospital 47
Assaf-Harofeh Medical Center 48
Clinical Trial Overview of Assaf-Harofeh Medical Center 48
University of Washington 49
Clinical Trial Overview of University of Washington 49
Hadassah Medical Organization 50
Clinical Trial Overview of Hadassah Medical Organization 50
Five Key Clinical Profiles 51
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75

List of Tables

Myalgia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Myalgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myalgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myalgia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Myalgia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Myalgia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Myalgia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Myalgia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Myalgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Myalgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Myalgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Myalgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Myalgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Myalgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Myalgia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Myalgia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Myalgia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Myalgia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Myalgia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Myalgia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Myalgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Myalgia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Myalgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Myalgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Myalgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorio Brasileiro de Biologia, 2014* 32
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Idea AG, 2014* 33
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hisamitsu Pharmaceutical Co., Inc., 2014* 34
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2014* 35
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dil Ltd., 2014* 36
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 37

Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Covigilance sro, 2014* 38
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cellex K.K., 2014* 39
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 40
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Acceleron Pharma, Inc., 2014* 41
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2014* 42
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurdistan University of Medical Sciences, 2014* 43
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014* 44
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2014* 45
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hartford Hospital, 2014* 46
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2014* 47
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2014* 48
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 49
Myalgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 50

List of Figures

Myalgia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Myalgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myalgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myalgia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Myalgia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Myalgia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Myalgia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Myalgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Myalgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Myalgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Myalgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Myalgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Myalgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Myalgia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Myalgia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Myalgia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Myalgia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Myalgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Myalgia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Myalgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Myalgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Myalgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 74

To order this report: Myalgia Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256141/Myalgia-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Fibromyalgia Is Not All In Your Head, New Research Confirms
2. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
3. Soterix Medical Inc. reports positive results from High-Definition tDCS Fibromyalgia Trial at Harvard Medical School
4. WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day
5. Myoclonus Global Clinical Trials Review, H2, 2014
6. Neuralgia Global Clinical Trials Review, H2, 2014
7. Multiple Sclerosis Global Clinical Trials Review, H2, 2014
8. Muscle Spasticity Global Clinical Trials Review, H2, 2014
9. Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014
10. Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014
11. Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016   ... that Nationwide Children,s Hospital signed a ... and accelerate the development of new cures. ... organizations representing over 57 million patients globally, biopharmaceutical ... working together to improve protocol design, site selection, ...
(Date:12/8/2016)... True Health Diagnostics today announced a ... and management expertise to hospital systems throughout ... doctors and patients to benefit from state-of-the-art biomarker ... Logo - http://photos.prnewswire.com/prnh/20161208/447162LOGO ... to contain costs, have struggled to keep up ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center ... loss and wellness program, at their world headquarters of Omni La Costa Resort & ... results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, cancer ... announced the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
Breaking Medicine News(10 mins):